| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.94▼ | 6.98▼ | 6.99▼ | 7.16▼ | 7.14▼ |
| MA10 | 6.95▼ | 7.00▼ | 7.06▼ | 7.17▼ | 6.66▲ |
| MA20 | 6.97▼ | 7.08▼ | 7.14▼ | 7.22▼ | 7.26▼ |
| MA50 | 7.00▼ | 7.19▼ | 7.23▼ | 6.68▲ | 9.46▼ |
| MA100 | 7.05▼ | 7.25▼ | 7.22▼ | 7.33▼ | 8.32▼ |
| MA200 | 7.14▼ | 7.22▼ | 6.94▼ | 8.78▼ | 37.28▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.007▼ | -0.022▼ | -0.038▼ | 0.156▲ |
| RSI | 38.289▼ | 31.078▼ | 33.282▼ | 48.708▼ | 44.119▼ |
| STOCH | 25.676 | 27.212 | 23.912 | 39.129 | 50.150 |
| WILL %R | -82.353▼ | -91.837▼ | -94.444▼ | -89.247▼ | -48.806 |
| CCI | -97.931 | -163.149▼ | -118.246▼ | -128.134▼ | 30.008 |
|
Friday, June 13, 2025 02:28 PM
Novavax Inc. closed 61.03% short of its 52-week high of $17.81, which the company achieved on July 26th.
|
|
Friday, June 13, 2025 08:30 AM
Novavax, Inc. faces profitability challenges despite a promising tech platform, with uncertain revenue streams. Click for my NVAX stock update.
|
|
Thursday, June 12, 2025 05:00 PM
Novavax, Inc. (Nasdaq: NVAX) today announced results of the initial cohort of its COVID-19-Influenza Combination (CIC) and stand-alone trivalent hemagglutinin nanoparticle seasonal influenza (tNIV ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/06/25 | 6.97 | 7.125 | 6.87 | 6.94 | 5,179,634 |
| 12/06/25 | 7.09 | 7.275 | 7.04 | 7.15 | 4,000,736 |
| 11/06/25 | 7.30 | 7.51 | 7.08 | 7.09 | 5,975,769 |
| 10/06/25 | 7.44 | 7.525 | 7.195 | 7.20 | 5,100,048 |
| 09/06/25 | 7.56 | 7.77 | 7.37 | 7.41 | 5,122,707 |
| 06/06/25 | 7.04 | 7.48 | 7.02 | 7.45 | 7,432,814 |
| 05/06/25 | 7.14 | 7.18 | 6.905 | 6.99 | 5,596,960 |
| 04/06/25 | 7.30 | 7.44 | 7.105 | 7.15 | 6,684,008 |
| 03/06/25 | 7.07 | 7.35 | 6.89 | 7.26 | 6,522,938 |
| 02/06/25 | 7.33 | 7.34 | 6.92 | 7.07 | 7,001,774 |
|
|
||||
|
|
||||
|
|